Drug Discovery News
-
CEPI selects Inovio to develop vaccine against coronavirus
Drug Discovery | News | 0 Comment | 28 Jan, 2020
US based Inovio Pharmaceuticals, has announced the Coalition for Epidemic Preparedness Innovations (CEPI) has awarded In...Read more
-
Darolutamide gets marketing authorization in Japan
Drug Discovery | News | 0 Comment | 24 Jan, 2020
The Japanese Ministry of Health, Labor and Welfare (MHLW) has granted marketing authorization for darolutamide, under th...Read more
-
RegeneRx Biopharma receives patent in Korea
Drug Discovery | News | 0 Comment | 23 Jan, 2020
US based RegeneRx Biopharmaceuticals, a clinical-stage drug development company focused on tissue protection, repai...Read more
-
Hitachi Chemical inks pact with Ori Biotech
Drug Discovery | News | 0 Comment | 23 Jan, 2020
Hitachi Chemical Advanced Therapeutics Solutions, LLC, a US subsidiary of Japanese firm Hitachi Chemical Co., Ltd....Read more
-
PhoreMost, Otsuka collaborate for multi drug discovery projects
Drug Discovery | News | 0 Comment | 22 Jan, 2020
PhoreMost Limited, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease target...Read more
-
ViiV Healthcare wins Japanese approval for Dovato to treat HIV-1
Drug Discovery | News | 0 Comment | 20 Jan, 2020
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as share...Read more
-
InterVenn Biosciences advances glycoproteomics for complex disease therapies
Drug Discovery | News | 0 Comment | 17 Jan, 2020
US based InterVenn Biosciences has announced multiple achievements in its development of AI-enabled glycoproteomics, as ...Read more
-
Charles River inks scientific collaboration with Takeda
Drug Discovery | News | 0 Comment | 16 Jan, 2020
US based company Charles River has announced a multi-year drug discovery collaboration with Japanese firm Takeda Pharmac...Read more
-
Hitachi starts commercial manufacturing of Zynteglo
Drug Discovery | News | 0 Comment | 15 Jan, 2020
apceth Biopharma GmbH, a subsidiary of Japan headquartered Hitachi Chemical Co., Ltd. and a leading company for the manu...Read more
-
FDA approves sNDA for Astellas’s antifungal drug
Drug Discovery | News | 0 Comment | 13 Jan, 2020
Japan based Astellas Pharma Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved its supplem...Read more
-
China approves AstraZeneca’s Lokelma to treat hyperkalaemia
Drug Discovery | News | 0 Comment | 07 Jan, 2020
AstraZeneca’s Lokelma (sodium zirconium cyclosilicate) has been approved in China for the treatment of a...Read more
-
China grants priority review to Luye Pharma's schizophrenia drug
Drug Discovery | News | 0 Comment | 02 Jan, 2020
Luye Pharma Group has announced that the New Drug Application (NDA) for Risperidone Extended-Release Microspheres for In...Read more
-
AstraZeneca’s triple-combination therapy gets approval in China for COPD
Drug Discovery | News | 0 Comment | 01 Jan, 2020
AstraZeneca has announced that budesonide/glycopyrronium/formoterol fumarate has been approved in China for the maintena...Read more
-
Luye Pharma seeks USFDA approval for antidepressant drug
Drug Discovery | News | 0 Comment | 30 Dec, 2019
China based Luye Pharma Group has announced submission of a new drug application (NDA) to the U.S. Food and Drug Adminis...Read more
-
USFDA approves Daiichi Sankyo and AstraZeneca’s breast cancer drug
Drug Discovery | News | 0 Comment | 26 Dec, 2019
Daiichi Sankyo and AstraZeneca have announced that the U.S. Food and Drug Administration (FDA) has approved ENHERTU®...Read more
-
Allergan gets FDA nod for acute migraine treatment
Drug Discovery | News | 0 Comment | 24 Dec, 2019
The U.S. Food and Drug Administration has approved Ubrelvy (ubrogepant) tablets for the acute (immediate) treatment of m...Read more
-
Eisai gets USFDA nod for insomnia drug
Drug Discovery | News | 0 Comment | 24 Dec, 2019
Eisai has announced that the U.S. Food and Drug Administration (FDA) approved DAYVIGO™ (lemborexant) 5 mg and...Read more
-
BeiGene cancer drug misses mark in Phase III study
Drug Discovery | News | 0 Comment | 20 Dec, 2019
China based BeiGene, a commercial-stage biopharmaceutical company focused on developing and commercializing innova...Read more
